Fresenius Kabi Pharmaceuticals (NASDAQ:APCVZ) previously reported that it has received approval from the U.S. Food and Drug Administration (FDA) to market Topotecan for Injection, and plans to launch immediately. Topotecan for Injection is therapeutically equivalent to the reference-listed drug Hycamtin®, which is currently marketed by the innovator GlaxoSmithKline, plc.

Global Hunter Corp. (TSX.V:BOB) (FSE:G5D) has built an outstanding portfolio of projects in the stable geopolitical geographies of Canada and Chile.

Click Here http://www.crwenewswire.com/?p=81650

Uranerz Energy Corp. (AMEX:URZ) previously reported that it has entered into a sales agreement with Haywood Securities (USA) Inc., pursuant to which the Company may, from time to time, offer and sell shares of its common stock having an aggregate offering price of up to US$20 million through Haywood, acting as agent for any sales made under an “at-the-market” issuance.

Validus Holdings, Ltd. (NYSE:VR) previously reported net income of $238.5 million, or $2.08 per diluted common share for the three months ended September 30, 2010, compared with net income of $499.2 million, or $5.21 per diluted common share, for the three months ended September 30, 2009.